Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

University of California, Irvine Chao Family Comprehensive Cancer Center

1 abstract

Abstract
A phase I study of irinotecan combined with BAY1895344 (ATR inhibitor) in advanced solid tumors: Results of ETCTN 10402 dose escalation.
Org: University of California, Irvine Chao Family Comprehensive Cancer Center, Division of Cancer Treatment and Diagnosis National Cancer Institute,